Biosimulation Market (By Product: Software, Services; By Application: Drug Development, Drug Discovery, Others; By End-use: Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global Biosimulation market size is expected to be worth around US$ 8.77 billion by 2030, according to a new report by Vision Research Reports.

The global Biosimulation market size was valued at US$ 2.20 billion in 2020 and is anticipated to grow at a CAGR of 25.4% during forecast period 2021 to 2030.

Growth Factors

Soaring need for advanced generation therapeutics owing to the growing prevalence of chronic diseases, such as cancer and diabetes, is stoking the growth of the biosimulation market.

Moreover, the rising geriatric population worldwide is playing an imperative role in the growth of the market. Aged people are highly susceptible to chronic diseases, which is augmenting the need for highly efficacious drugs. In addition, a growing number of drug resistance cases, high drug relapse rates, and limited availability drugs to treat diseases such as AIDS are leading to high clinical urgency for the adoption of biosimulation in applications such as drug development and drug discovery.

Surging demand for biosimulation software and services can also be attributed to their higher cost-efficiency. This cost efficiency is a result of ability to predict toxicity, adverse reactions, and efficacy of investigational drugs during early stages of product development, thus limiting the probability of drug relapse & adverse events at later stages.

Report Highlights

Software accounted for the dominant share in the market in 2015. The dominant share can be attributed to the availability of a wide range of application-specific software that suits the interests and needs of researchers. For instance, Rhenovia Pharma provides software that specializes in simulation of the mechanism of CNS-specific drugs. The software is also being increasingly incorporated in applications, such as defense, food, and aviation.

The services segment is poised to witness the highest CAGR during the forecast period. The growth of the segment can be attributed to increasingly complex and multi-layered drug development systems, in which biosimulation services may prove to be imperative. The aforementioned is expected to be achieved through the formulation of new combination therapies that are more precise in nature. Key players are highly involved in providing an extensive array of services, which simplifies the overall biosimulation process. These services result in reduction of overall expenditure and thus, become the preference for clinicians and researchers.

Drug development held the largest share of over 58.0% in 2015. Rising number of government initiatives promoting the incorporation of advanced software is contributing to the growth of the segment. For instance, the FDA’s 2004 critical path initiative report highlights the importance of this approach for drug development and suggests that it can be incorporated as an efficient predictive tool.

On the other hand, drug discovery is anticipated to post a remarkable CAGR throughout the forecast period. Spiraling the adoption of biosimulation in areas such as pharmacogenomics and pharmacogenetics is supplementing the growth of the segment. In addition, growing demand for the development of advanced therapeutics in conditions such as pregnancy, for which a large number of drugs cannot be administered, is one of the key growth stimulants for this segment.

Pharmaceutical & biotechnology companies accounted for a substantial share of over 57.0% in the biosimulation market in 2015. Strong demand for biosimulation in these companies can be attributed to constant efforts of key companies to prolong lifecycles of off-patent drugs and discover drug variants by adopting a computer modeling approach. For instance, Rhenovia Pharma Ltd. adopted silico models for the identification of better treatment approaches for bipolar disorders, depression, schizophrenia, and Alzheimer’s disease.

CROs are estimated to progress at a phenomenal CAGR during the forecast period. Rising inclination of companies to reduce the overall expenditure is projected to escalate the growth of the segment. Other benefits primarily include enhanced productivity and a higher focus on core areas of development, which are critical to the growth of a company.

North America was at the forefront of the growth of the market, representing over half of the overall market revenue. Growing number of collaborations by key players for improving drug discovery capabilities is helping the market gain tremendous momentum. Moreover, the adoption of in-silico models during enforcement of regulatory policies to ensure high patient safety & treatment standards is further contributing to the share attained by North America.

Asia Pacific is likely to witness exponential growth during the forecast period owing to increasing preference for contract research organizations, rising healthcare IT expenditure, and consistent up-gradation in healthcare infrastructure. In addition, burgeoning R&D activities in emerging economies are poised to present the region with significant growth opportunities.

Key Players

Dassault Systemes SA; Certara USA, Inc.; Advanced Chemistry Development, Inc.; Schrodinger, Inc.; Genedata AG; and Rhenovia Pharma Ltd.

Market Segmentation

• Product Outlook 

  • Software

  • Services

    • In-house Services

    • Contract Services

• Application Outlook 

  • Drug Development

  • Drug Discovery

  • Others

• End-use Outlook 

  • Pharmaceutical & Biotechnology Companies

  • CROs

  • Regulatory Authorities

  • Academic Research Institutions

• Regional Outlook 

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa

The Biosimulation market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Biosimulation market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Biosimulation market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosimulation market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Biosimulation market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Biosimulation capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Biosimulation by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Biosimulation market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Biosimulation market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Biosimulation market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Biosimulation industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Biosimulation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Biosimulation market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Biosimulation market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Biosimulation market. These factors have benefited the growth of the global market for Biosimulation. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Biosimulation. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Biosimulation are as follows:

• Historic Year: 2017-2020
• Base Year: 2021
• Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.